31 July 2024

Circulars issued regarding Field Safety Corrective Action and Voluntary Recalls of certain products batches

Reference: CIR-2024-00000134

 

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated

 

Circular No.6111 for the year 2024 regarding notifications of Field Safety Corrective Action

 

Circular No.5921 for the year 2024 regarding Voluntary Recall of One lot of Pharmaceutical Product Budesonide Inhalation Suspension 0.5mg/2ml

 

Circular No.5950 for the year 2024 Voluntary Recall of One Batch of Voluntary Recall of Olfast Granules

 

Circular No.5923 for the year 2024 regarding Recall of Pharmaceutical Product Lot Rezzayo 200mg Vial

 

Circular No.5922 for the year 2024 Voluntary Recall of one batch of pharmaceutical product Septanest SP

 

 

 

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Olfast Granules -سحب طوعي لتشغيلة واحدة من المنتج الطبي --.pdf:

View Document

Rezzayo 200mg vial - سحب تشغيلة من المنتج الطبي --.pdf:

View Document

Septanest SP- سحب طوعي لتشغيلة من المنتج الطبي++.pdf:

View Document

Budesonide Inhalation Suspension 0.5mg -2ml - ---سحب طوعي لتشغيلة واحدة من المنتج الطبي.pdf:

View Document

تقارير سلامة الوسائل الطبية -++29-07-2024.pdf:

View Document